Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Naturally occurring peptide may tackle the ‘root cause’ of obesity-related conditions Research shows the peptide called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases
News Dr Pavlovic appointed as Editor in Chief of the Journal of Molecular and Cellular Cardiology PLUS
News Heart surgery and impact on mental health among new priorities for congenital heart disease research
15 March 2021 Karger: Spotlight on Professor Dipak Kotecha, Associate Editor Article about Professor Dipak Kotecha, Associate Editor of Karger and Professor of Cardiology at the Institute of Cardiovascular Sciences, where he talks about himself and his research.
01 February 2021 Latest trial led by Birmingham Professor shows digoxin is effective in treating atrial fibrillation A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when treating patients with permanent atrial fibrillation.
27 January 2021 Sir Henry Wellcome Fellowship awarded to Dr Christopher O'Shea Dr Christopher O'Shea from at the Institute of Cardiovascular Sciences has been awarded a prestigious Postdoctoral Fellowship from the Wellcome Trust.
13 January 2021 Hunterian Professorship awarded to Birmingham Clinician Scientist Mr Nigel Drury, Clinician Scientist in Paediatric Cardiac Surgery at the University of Birmingham, has received the prestigious Hunterian Professorship.
04 January 2021 Institute of Cardiovascular Sciences welcomes new Birmingham Fellow Dr James Guggenheim has been appointed as a Birmingham Fellow with the Institute of Cardiovascular Sciences at the University of Birmingham.